Applying a Novel Approach to Modulating
NMDA Receptors to Develop Improved CNS Therapies

Overview:

Naurex is applying its novel platform and chemistries to discover and develop compounds that modulate the NMDA receptor in a new way. Naurex programs based on this new mechanism have high potential as therapies for various CNS diseases, including mood and anxiety disorders, cognitive disorders, developmental disorders, neurodegeneration, neuropathic pain and addiction.

  

First Clinical Target:

Treatment-resistant depression